Validating C. elegans healthspan model for better understanding factors causing health and disease, to develop evidence based prevention, diagnostic, therapeutic and other strategies.

Acronym

Ageing with elegans

Description of the granted funding

Healthspan (the life period when one is generally healthy and free from serious disease) depends on nature (genetic make-up) and nurture (environmental influences, from the earliest stages of development throughout life). Genetic studies increasingly reveal mutations and polymorphisms that may affect healthspan. Similarly, claims abound about lifestyle modifications or treatments improving healthspan. In both cases, rigorous testing is hampered by the long lifespan of model organisms like mice (let alone humans) and the difficulty of introducing genetic changes to examine the phenotype of the altered genome. We will develop C. elegans as a healthspan model. Already validated extensively as an ageing model, this organism can be readily modified genetically, and effects of environmental manipulations on healthspan can be measured in days or weeks. Once validated as a healthspan model, it can be used for an initial assessment of preventive and therapeutic measures for humans, as well as for risk identification and the initial evaluation of potential biomarkers. It will also prove useful to study interactions between genetic and various environmental factors.
Show more

Starting year

2015

End year

2020

Granted funding

AARHUS UNIVERSITET (DK)
500 317.5 €
Participant
ABIOMICS EUROPE KFT (HU)
347 312.5 €
Participant
UNIVERSITATSMEDIZIN ROSTOCK (DE)
387 500 €
Participant
AnalytiCon Discovery GmbH (DE)
533 531.25 €
Participant
BIOPOLIS SL (ES)
532 075 €
Participant
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA CORP (US)
361 634.25 €
Participant
HUMBOLDT-UNIVERSITAET ZU BERLIN (DE)
621 995.15 €
Participant
TSINGHUA UNIVERSITY (CN)
Participant
TARTU ULIKOOL (EE)
185 750 €
Participant
AGILENT TECHNOLOGIES BELGIUM NV (BE)
188 437.5 €
Participant
KAROLINSKA INSTITUTET (SE)
251 726 €
Participant
ISTITUTO SUPERIORE DI SANITA (IT)
507 250 €
Participant
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH (CH)
Participant
UNIVERSITEIT GENT (BE)
468 425 €
Participant
KATHOLIEKE UNIVERSITEIT LEUVEN (BE)
1 205 976.35 €
Coordinator
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (UK)
308 500 €
Participant

Amount granted

6 573 681 €

Funder

European Union

Funding instrument

Research and Innovation action

Framework programme

Horizon 2020 Framework Programme

Call

Programme part
Health (5290)
Understanding health, wellbeing and disease (5291)
Topic
Understanding health, ageing and disease: determinants, risk factors and pathways (PHC-01-2014)
Call ID
H2020-PHC-2014-two-stage

Other information

Funding decision number

633589

Identified topics

health care